U.S. FDA panel recommends approval of Johnson & Johnson's depression drug

11:51am PST - February 12th, 2019    ketamine - Reuters

An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.